Request for Covid-19 Impact Assessment of this Report
The United States Crysvita market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Crysvita market, reaching US$ million by the year 2028. As for the Europe Crysvita landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Crysvita players cover Kyowa Kirin, Ultragenyx Pharmaceutical, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Crysvita market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
10 mg
20 mg
30 mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Kyowa Kirin
Ultragenyx Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Crysvita Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Crysvita by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Crysvita by Country/Region, 2017, 2022 & 2028
2.2 Crysvita Segment by Type
2.2.1 10 mg
2.2.2 20 mg
2.2.3 30 mg
2.3 Crysvita Sales by Type
2.3.1 Global Crysvita Sales Market Share by Type (2017-2022)
2.3.2 Global Crysvita Revenue and Market Share by Type (2017-2022)
2.3.3 Global Crysvita Sale Price by Type (2017-2022)
2.4 Crysvita Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Crysvita Sales by Application
2.5.1 Global Crysvita Sale Market Share by Application (2017-2022)
2.5.2 Global Crysvita Revenue and Market Share by Application (2017-2022)
2.5.3 Global Crysvita Sale Price by Application (2017-2022)
3 Global Crysvita by Company
3.1 Global Crysvita Breakdown Data by Company
3.1.1 Global Crysvita Annual Sales by Company (2020-2022)
3.1.2 Global Crysvita Sales Market Share by Company (2020-2022)
3.2 Global Crysvita Annual Revenue by Company (2020-2022)
3.2.1 Global Crysvita Revenue by Company (2020-2022)
3.2.2 Global Crysvita Revenue Market Share by Company (2020-2022)
3.3 Global Crysvita Sale Price by Company
3.4 Key Manufacturers Crysvita Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Crysvita Product Location Distribution
3.4.2 Players Crysvita Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Crysvita by Geographic Region
4.1 World Historic Crysvita Market Size by Geographic Region (2017-2022)
4.1.1 Global Crysvita Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Crysvita Annual Revenue by Geographic Region
4.2 World Historic Crysvita Market Size by Country/Region (2017-2022)
4.2.1 Global Crysvita Annual Sales by Country/Region (2017-2022)
4.2.2 Global Crysvita Annual Revenue by Country/Region
4.3 Americas Crysvita Sales Growth
4.4 APAC Crysvita Sales Growth
4.5 Europe Crysvita Sales Growth
4.6 Middle East & Africa Crysvita Sales Growth
5 Americas
5.1 Americas Crysvita Sales by Country
5.1.1 Americas Crysvita Sales by Country (2017-2022)
5.1.2 Americas Crysvita Revenue by Country (2017-2022)
5.2 Americas Crysvita Sales by Type
5.3 Americas Crysvita Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Crysvita Sales by Region
6.1.1 APAC Crysvita Sales by Region (2017-2022)
6.1.2 APAC Crysvita Revenue by Region (2017-2022)
6.2 APAC Crysvita Sales by Type
6.3 APAC Crysvita Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Crysvita by Country
7.1.1 Europe Crysvita Sales by Country (2017-2022)
7.1.2 Europe Crysvita Revenue by Country (2017-2022)
7.2 Europe Crysvita Sales by Type
7.3 Europe Crysvita Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Crysvita by Country
8.1.1 Middle East & Africa Crysvita Sales by Country (2017-2022)
8.1.2 Middle East & Africa Crysvita Revenue by Country (2017-2022)
8.2 Middle East & Africa Crysvita Sales by Type
8.3 Middle East & Africa Crysvita Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Crysvita
10.3 Manufacturing Process Analysis of Crysvita
10.4 Industry Chain Structure of Crysvita
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Crysvita Distributors
11.3 Crysvita Customer
12 World Forecast Review for Crysvita by Geographic Region
12.1 Global Crysvita Market Size Forecast by Region
12.1.1 Global Crysvita Forecast by Region (2023-2028)
12.1.2 Global Crysvita Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Crysvita Forecast by Type
12.7 Global Crysvita Forecast by Application
13 Key Players Analysis
13.1 Kyowa Kirin
13.1.1 Kyowa Kirin Company Information
13.1.2 Kyowa Kirin Crysvita Product Offered
13.1.3 Kyowa Kirin Crysvita Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Kyowa Kirin Main Business Overview
13.1.5 Kyowa Kirin Latest Developments
14 Research Findings and Conclusion
Table 1. Crysvita Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Crysvita Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 10 mg
Table 4. Major Players of 20 mg
Table 5. Major Players of 30 mg
Table 6. Global Crysvita Sales by Type (2017-2022) & (K Units)
Table 7. Global Crysvita Sales Market Share by Type (2017-2022)
Table 8. Global Crysvita Revenue by Type (2017-2022) & ($ million)
Table 9. Global Crysvita Revenue Market Share by Type (2017-2022)
Table 10. Global Crysvita Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Crysvita Sales by Application (2017-2022) & (K Units)
Table 12. Global Crysvita Sales Market Share by Application (2017-2022)
Table 13. Global Crysvita Revenue by Application (2017-2022)
Table 14. Global Crysvita Revenue Market Share by Application (2017-2022)
Table 15. Global Crysvita Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Crysvita Sales by Company (2020-2022) & (K Units)
Table 17. Global Crysvita Sales Market Share by Company (2020-2022)
Table 18. Global Crysvita Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Crysvita Revenue Market Share by Company (2020-2022)
Table 20. Global Crysvita Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Crysvita Producing Area Distribution and Sales Area
Table 22. Players Crysvita Products Offered
Table 23. Crysvita Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Crysvita Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Crysvita Sales Market Share Geographic Region (2017-2022)
Table 28. Global Crysvita Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Crysvita Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Crysvita Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Crysvita Sales Market Share by Country/Region (2017-2022)
Table 32. Global Crysvita Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Crysvita Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Crysvita Sales by Country (2017-2022) & (K Units)
Table 35. Americas Crysvita Sales Market Share by Country (2017-2022)
Table 36. Americas Crysvita Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Crysvita Revenue Market Share by Country (2017-2022)
Table 38. Americas Crysvita Sales by Type (2017-2022) & (K Units)
Table 39. Americas Crysvita Sales Market Share by Type (2017-2022)
Table 40. Americas Crysvita Sales by Application (2017-2022) & (K Units)
Table 41. Americas Crysvita Sales Market Share by Application (2017-2022)
Table 42. APAC Crysvita Sales by Region (2017-2022) & (K Units)
Table 43. APAC Crysvita Sales Market Share by Region (2017-2022)
Table 44. APAC Crysvita Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Crysvita Revenue Market Share by Region (2017-2022)
Table 46. APAC Crysvita Sales by Type (2017-2022) & (K Units)
Table 47. APAC Crysvita Sales Market Share by Type (2017-2022)
Table 48. APAC Crysvita Sales by Application (2017-2022) & (K Units)
Table 49. APAC Crysvita Sales Market Share by Application (2017-2022)
Table 50. Europe Crysvita Sales by Country (2017-2022) & (K Units)
Table 51. Europe Crysvita Sales Market Share by Country (2017-2022)
Table 52. Europe Crysvita Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Crysvita Revenue Market Share by Country (2017-2022)
Table 54. Europe Crysvita Sales by Type (2017-2022) & (K Units)
Table 55. Europe Crysvita Sales Market Share by Type (2017-2022)
Table 56. Europe Crysvita Sales by Application (2017-2022) & (K Units)
Table 57. Europe Crysvita Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Crysvita Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Crysvita Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Crysvita Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Crysvita Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Crysvita Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Crysvita Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Crysvita Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Crysvita Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Crysvita
Table 67. Key Market Challenges & Risks of Crysvita
Table 68. Key Industry Trends of Crysvita
Table 69. Crysvita Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Crysvita Distributors List
Table 72. Crysvita Customer List
Table 73. Global Crysvita Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Crysvita Sales Market Forecast by Region
Table 75. Global Crysvita Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Crysvita Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Crysvita Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Crysvita Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Crysvita Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Crysvita Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Crysvita Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Crysvita Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Crysvita Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Crysvita Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Crysvita Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Crysvita Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Crysvita Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Crysvita Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Crysvita Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Crysvita Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Crysvita Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Crysvita Revenue Market Share Forecast by Application (2023-2028)
Table 93. Kyowa Kirin Basic Information, Crysvita Manufacturing Base, Sales Area and Its Competitors
Table 94. Kyowa Kirin Crysvita Product Offered
Table 95. Kyowa Kirin Crysvita Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Kyowa Kirin Main Business
Table 97. Kyowa Kirin Latest Developments
Table 98. Ultragenyx Pharmaceutical Basic Information, Crysvita Manufacturing Base, Sales Area and Its Competitors
Table 99. Ultragenyx Pharmaceutical Crysvita Product Offered
Table 100. Ultragenyx Pharmaceutical Crysvita Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Ultragenyx Pharmaceutical Main Business
Table 102. Ultragenyx Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Crysvita
Figure 2. Crysvita Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Crysvita Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Crysvita Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Crysvita Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 10 mg
Figure 10. Product Picture of 20 mg
Figure 11. Product Picture of 30 mg
Figure 12. Global Crysvita Sales Market Share by Type in 2021
Figure 13. Global Crysvita Revenue Market Share by Type (2017-2022)
Figure 14. Crysvita Consumed in Hospitals
Figure 15. Global Crysvita Market: Hospitals (2017-2022) & (K Units)
Figure 16. Crysvita Consumed in Clinics
Figure 17. Global Crysvita Market: Clinics (2017-2022) & (K Units)
Figure 18. Crysvita Consumed in Others
Figure 19. Global Crysvita Market: Others (2017-2022) & (K Units)
Figure 20. Global Crysvita Sales Market Share by Application (2017-2022)
Figure 21. Global Crysvita Revenue Market Share by Application in 2021
Figure 22. Crysvita Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Crysvita Revenue Market Share by Company in 2021
Figure 24. Global Crysvita Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Crysvita Revenue Market Share by Geographic Region in 2021
Figure 26. Global Crysvita Sales Market Share by Region (2017-2022)
Figure 27. Global Crysvita Revenue Market Share by Country/Region in 2021
Figure 28. Americas Crysvita Sales 2017-2022 (K Units)
Figure 29. Americas Crysvita Revenue 2017-2022 ($ Millions)
Figure 30. APAC Crysvita Sales 2017-2022 (K Units)
Figure 31. APAC Crysvita Revenue 2017-2022 ($ Millions)
Figure 32. Europe Crysvita Sales 2017-2022 (K Units)
Figure 33. Europe Crysvita Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Crysvita Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Crysvita Revenue 2017-2022 ($ Millions)
Figure 36. Americas Crysvita Sales Market Share by Country in 2021
Figure 37. Americas Crysvita Revenue Market Share by Country in 2021
Figure 38. United States Crysvita Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Crysvita Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Crysvita Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Crysvita Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Crysvita Sales Market Share by Region in 2021
Figure 43. APAC Crysvita Revenue Market Share by Regions in 2021
Figure 44. China Crysvita Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Crysvita Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Crysvita Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Crysvita Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Crysvita Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Crysvita Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Crysvita Sales Market Share by Country in 2021
Figure 51. Europe Crysvita Revenue Market Share by Country in 2021
Figure 52. Germany Crysvita Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Crysvita Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Crysvita Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Crysvita Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Crysvita Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Crysvita Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Crysvita Revenue Market Share by Country in 2021
Figure 59. Egypt Crysvita Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Crysvita Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Crysvita Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Crysvita Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Crysvita Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Crysvita in 2021
Figure 65. Manufacturing Process Analysis of Crysvita
Figure 66. Industry Chain Structure of Crysvita
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...